Now, researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) are developing an approach that could improve healing by increasing blood flow directly at the wound site.
With a new tool that could transform how that game is played, UC Berkeley researchers have discovered a previously unrecognized signal in electrocardiograms that can better detect high-risk patients before their hearts stop.
Researchers found that exposure to bright artificial light in the evening, especially between 8 p.m. and 11:30 p.m., may significantly increase the risk of developing serious eye diseases later in life.
Younger generations are now aging faster than their parents and grandparents, and this aging gap could explain the rise in early-onset cancers.
Decision delivers the first ADC-based regimens for previously untreated triple-negative breast cancer across PD-L1 status, a PD-L1-positive Keytruda combination plus a monotherapy option for immunotherapy-ineligible patients.
A tiny silk sticker that visibly shows vital health signals, read by an AI system, could change how we care for the tiniest patients
Cyclana Bio, a biotechnology company pioneering tissue-level approaches to women’s health, has announced it has received Health Research Authority (HRA) and Research Ethics Committee (REC) approval for its 500-patient clinical observational study, PEMP (Predicting Endometriosis Mechanisms and Populations).
Spotlight Medical, a Paris-based oncology diagnostics company, has announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) 2017/746).